期刊文献+

奥曲肽治疗食管胃底静脉曲张破裂出血的疗效观察

Observation on the Curative Effect of Octreotide in the Treatment of Bleeding Caused by Rupture of Esophageal and Gastric Varices
下载PDF
导出
摘要 目的:探讨奥曲肽治疗食管胃底静脉曲张破裂出血的疗效.方法:收集食管胃底静脉曲张破裂出血病例40例,根据是否应用奥曲肽,将病例分为奥曲肽治疗组(治疗组)和非奥曲肽治疗组(对照组),比较观察两组治疗效果.结果:奥曲肽治疗食管胃底静脉曲张破裂出血效果明显优于非奥曲肽治疗组,差异有统计学意义.结论:奥曲肽治疗食管胃底静脉曲张破裂出血疗效确切. Objective: To investigate the curative effect of octreotide in the treatment of bleeding caused by rupture of esophageal and gastric varices. Methods: Depending on whether application of octreotide, 40 patients with bleeding caused by rupture of esophageal and gastric varices were divided into octreotide treatment group and the non-octreotide treatment group (control group), compared the curative effects of the two groups. Results: The curative effect of octreotide treatment group was much better than non-octreotide group, the difference was statistically significant. Conclusion: Octreotide has an obvious curative effect in the treatment of bleeding caused by rupture of esophageal and gastric varices.
作者 李洪清
出处 《内蒙古民族大学学报(自然科学版)》 2009年第6期697-698,共2页 Journal of Inner Mongolia Minzu University:Natural Sciences
关键词 奥曲肽 食管胃底静脉曲张破裂 出血 Oetreotide Esophageal and gastric variees rupture Bleeding
  • 相关文献

参考文献5

二级参考文献25

  • 1王立新,林三仁,董秀云,杨雪玲,周丽雅.铝碳酸镁对胃粘膜保护的实验研究[J].胃肠病学,1999,4(3):137-139. 被引量:13
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 3Okuda K,Ohnishi K,Kimura K,et al.Incidence of portal vein thrombosis in liver cirrhosis-an angiographic study in 708 patients[J].Gastroenterology,1985,89(2):279-286.
  • 4Erkan O,Bozdayi AM,Disibeyaz S,et al.Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis[J].Eur J Gastroenterol Hepatol,2005,17(3):339-343.
  • 5Amitrano L,Braneaccio V,Guardasoione MA,et al.Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis[J].Hepatology,2000,31(2):345-348.
  • 6Amitrano L,Guardascione MA,Brancaccio V,et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis[J].J Hepatol,2004,40(5):736-741.
  • 7Romero GM,Suarez GE,Lopez LD,et al.Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis[J].J Clin Gastroenterol,2000,31(3):237-240.
  • 8Fimognari FL,De Santis A,Piccheri C,et al.Evaluation of D-dimet and factor Ⅷ in cirrhotic patients with asymptomatie portal venous thrombosis[J].J Lab Clin Med,2005,146(4):238-243.
  • 9Mangia A,Villani MR,Cappucci G,et al.Causes of portal venous thrombosis in cirrhotic patients:the role of genetic and acquired factors[J].Ear J Gastroenterol Hepatol,2005,17(7):745-751.
  • 10Guth PH.Aures D,Paulsen G.Topical aspirin plus HCl gastric lesions in the rat.Cytoprotective effect of prostagladin.cimetidine,and probanthine,Gastroenterology,1979,76:88-93.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部